The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 21, 2023

Filed:

Feb. 28, 2022
Applicants:

Baxter International Inc., Deerfield, IL (US);

Baxter Healthcare SA, Glattpark, CH;

Inventors:

Neil Tiwari, Wood Dale, IL (US);

Joshua James Miller, Wilmette, IL (US);

Marc Steven Minkus, Bannockburn, IL (US);

Matthew R. Muller, Lindenhurst, IL (US);

Derek Wiebenson, Zurich, CH;

Douglas L. Wilkerson, Gurnee, IL (US);

Timothy G. Robinson, Easton, PA (US);

Anders J. Wellings, Belleair Beach, FL (US);

Kathryn Louise Hansbro, Bala Cynwyd, PA (US);

Borut Cizman, Highwood, IL (US);

Brian S. Kunzeman, Grayslake, IL (US);

Robin D. Cooper, Wauconda, IL (US);

Timothy L. Kudelka, Lindehurst, IL (US);

Angelo A. Sarto, Franksville, WI (US);

Steve Joseph Lindo, Chicago, IL (US);

Jostein Baustad, Evanston, IL (US);

Duston Mounts, The Colony, TX (US);

Shafali Hill, Gurnee, IL (US);

Assignees:

Baxter International Inc., Deerfield, IL (US);

Baxter Healthcare SA, Glattpark, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/14 (2006.01); A61M 1/28 (2006.01); G06F 8/65 (2018.01); G16H 40/63 (2018.01); G16H 40/40 (2018.01); G16H 10/60 (2018.01); G06Q 30/0601 (2023.01); A61M 1/16 (2006.01); A61M 1/34 (2006.01); A61M 1/36 (2006.01); G16H 20/17 (2018.01); G16H 20/40 (2018.01); G16H 40/67 (2018.01); G16H 20/10 (2018.01);
U.S. Cl.
CPC ...
A61M 1/14 (2013.01); A61M 1/1603 (2014.02); A61M 1/28 (2013.01); A61M 1/282 (2014.02); A61M 1/288 (2014.02); A61M 1/34 (2013.01); A61M 1/36 (2013.01); G06F 8/65 (2013.01); G06Q 30/0601 (2013.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 20/17 (2018.01); G16H 20/40 (2018.01); G16H 40/40 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); A61M 2205/3553 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/50 (2013.01);
Abstract

A renal therapy system is disclosed. In an example, the renal therapy system includes a user interface device, such as a tablet computer. The renal therapy system also includes a renal therapy machine configured to perform a renal therapy. The renal therapy machine includes a data transfer interface configured to communicatively couple to the user interface device, a dialysis fluid pump, and a processor that operates a connectivity agent having an activated mode and a deactivated mode. When in the activated mode, the connectivity agent enables the processor to send data related to a performance of the renal therapy to a system hub. In the deactivated mode, the processor is prevented from sending the data to or receiving any data from the system hub. The user interface device is configured to receive data from and send data to the processor regardless of a status of the connectivity agent.


Find Patent Forward Citations

Loading…